BioAmber Inc.
BIOA
BIOA was delisted on the 8th of February, 2018.
35 hedge funds and large institutions have $66M invested in BioAmber Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 3 closing their positions.
38,350% more call options, than puts
Call options by funds: $769K | Put options by funds: $2K
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
14% more capital invested
Capital invested by funds: $58.1M → $66M (+$7.85M)
3% more funds holding
Funds holding: 34 → 35 (+1)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$631K |
| 2 |
LPL Financial
San Diego,
California
|
+$210K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$44.6K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.5K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$35.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$747K |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$495K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$453K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$427K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$85.6K |
BIOA Hedge Fund Activity: Q4 2015 in Review
35 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q4 2015, worth a combined $66M — up 14% from $58.1M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BIOA positions and 3 closed out — a net gain of 1 holder — while 8 added to existing stakes and 10 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $631K. The largest seller was Royce & Associates, cutting an estimated $747K.
- 35 institutional investors held BioAmber Inc. (BIOA) as of Q4 2015, up from 34 in Q3 2015.
- Funds reported $66M of BioAmber Inc. stock for Q4 2015, up 14% quarter-over-quarter.
- 4 funds opened new BioAmber Inc. positions in Q4 2015 and 3 closed out, a net change of +1 holder.
- The largest BioAmber Inc. buyer in Q4 2015 was Levin Capital Strategies, an estimated $631K added.
- The largest BioAmber Inc. seller in Q4 2015 was Royce & Associates, an estimated $747K sold.
Based on aggregated 13F filings for Q4 2015.